CHEMOTHERAPY IN HEAD AND NECK-CANCER .1. MANAGEMENT OF RECURRENT OR METASTATIC DISEASE

被引:0
作者
GEBBIA, V
ZERILLO, G
GEBBIA, N
AGOSTARA, B
CALLARI, A
RAUSA, L
机构
关键词
HEAD NECK CANCER; SYSTEMIC CHEMOTHERAPY; METASTATIC DISEASE;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This paper is an up-dated review of the role of systemic chemotherapy in the management of recurrent and/or metastatic head and neck carcinoma.
引用
收藏
页码:244 / 259
页数:16
相关论文
共 50 条
  • [41] Predictive value of skin invasion in recurrent head and neck cancer patients treated by hypofractionated stereotactic re-irradiation using a cyberknife
    Hideya Yamazaki
    Mikio Ogita
    Kengo Himei
    Satoaki Nakamura
    Gen Suzuki
    Tadayuki Kotsuma
    Ken Yoshida
    Yasuo Yoshioka
    Radiation Oncology, 10
  • [42] Free Colon Tissue Transfer for the Management of Xerostomia in Head and Neck Cancer Patients: A Bacteriological Study and Clinical Case Series
    Lin, Ying-Sheng
    Mousavi, Seyed Abolghasem
    Chen, Hung-Chi
    JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2022, 75 (08) : 2676 - 2683
  • [43] Is anti-PD-1 immunotherapy a means for post-irradiation tumor clearance in head and neck cancer?
    Koukourakis, Ioannis M.
    Papadimitriou, Marios
    Desse, Dimitra
    Zygogianni, Anna
    Papadimitriou, Christos
    Koukourakis, Michael, I
    MEDICAL ONCOLOGY, 2022, 39 (12)
  • [44] Is anti-PD-1 immunotherapy a means for post-irradiation tumor clearance in head and neck cancer?
    Ioannis M. Koukourakis
    Marios Papadimitriou
    Dimitra Desse
    Anna Zygogianni
    Christos Papadimitriou
    Michael I. Koukourakis
    Medical Oncology, 39
  • [45] The efficacy of taxane chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers
    Kriege, Mieke
    Jager, Agnes
    Hooning, Maartje J.
    Huijskens, Elisabeth
    Blom, Jannet
    van Deurzen, Carolien H. M.
    Bontenbal, Marijke
    Collee, J. Margriet
    Menke-Pluijmers, Marian B. E.
    Martens, John W. M.
    Seynaeve, Caroline
    CANCER, 2012, 118 (04) : 899 - 907
  • [46] p53 and bcl-2 expression in locally advanced squamous cell head-neck cancer treated with platinum based chemotherapy and radiotherapy
    Giatromanolaki, A
    Koukourakis, M
    Zaramboukas, T
    Skordalaki, A
    Arapantoni, P
    Georgoulias, V
    Fountzilas, G
    ANTICANCER RESEARCH, 1998, 18 (6B) : 4685 - 4692
  • [47] Hormone Receptor Status and HER2 Expression in Primary Breast Cancer Compared With Synchronous Axillary Metastases or Recurrent Metastatic Disease
    Rossi, Sabrina
    Basso, Michele
    Strippoli, Antonia
    Dadduzio, Vincenzo
    Cerchiaro, Eleonora
    Le, Rosalba Bari
    D'Argento, Ettore
    Cassano, Alessandra
    Schinzari, Giovanni
    Barone, Carlo
    CLINICAL BREAST CANCER, 2015, 15 (05) : 307 - 312
  • [48] Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiation
    Takiar, Vinita
    Akay, Catherine L.
    Stauder, Michael C.
    Tereffe, Welela
    Alvarez, Ricardo H.
    Hoffman, Karen E.
    Perkins, George H.
    Strom, Eric A.
    Buchholz, Thomas A.
    Ueno, Naoto T.
    Babiera, Gildy
    Woodward, Wendy A.
    SPRINGERPLUS, 2014, 3 : 1 - 9
  • [49] Chemoradiation therapy using radiotherapy, systemic chemotherapy with 5-fluorouracil and nedaplatin, and intra-arterial infusion using carboplatin for locally advanced head and neck cancer - Phase II study
    Fuwa, Nobukazu
    Kodaira, Takesi
    Furutani, Kazuhisa
    Tachibana, Hiroyuki
    Nakamura, Tatsuya
    Daimon, Takasi
    ORAL ONCOLOGY, 2007, 43 (10) : 1014 - 1020
  • [50] A matched-pair comparison of intensity-modulated radiation therapy with cetuximab versus intensity-modulated radiation therapy with platinum-based chemotherapy for locally advanced head neck cancer
    Huang, Jiayi
    Baschnagel, Andrew M.
    Chen, Peter
    Gustafson, Gregory
    Jaiyesmi, Ishmael
    Folbe, Mitchell
    Ye, Hong
    Akervall, Jan
    Krauss, Daniel
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (02) : 240 - 246